Cadrenal Therapeutics Inc. Common Stock

CVKD | NASDAQ

$1.10

+$0.01 (+0.92%)

Sep 22, 2026, 12:41 PM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022
Cash & Equivalents	4.01M	10.02M	8.4M	32.59K
Short-Term Investments	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	2.17K	3.79K	3.79K	-526.01K
Receivables	5.1K	38.15K	37.25K	n/a
Inventory	n/a	n/a	n/a	n/a
Other Current Assets	306.48K	14.45K	n/a	672.3K
Total Current Assets	4.32M	10.11M	8.49M	727.6K
Property-Plant & Equipment	5.17K	6.94K	23.29K	44.59K
Goodwill & Intangibles	n/a	n/a	n/a	n/a
Total Long-Term Assets	7.34K	10.74K	27.08K	50.58K
Total Assets	4.33M	10.12M	8.52M	778.17K
Account Payables	650.66K	1.5M	167.32K	404.9K
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	43.73K
Other Current Liabilities	733.2K	966.58K	596.13K	605.29K
Total Current Liabilities	1.59M	2.68M	826.88K	1.33M
Long-Term Debt	n/a	n/a	n/a	553.34K
Other Long-Term Liabilities	n/a	n/a	n/a	4.42M
Total Long-Term Liabilities	n/a	n/a	n/a	4.99M
Total Liabilities	1.59M	2.68M	826.88K	6.33M
Total Debt	n/a	n/a	21.35K	640.71K
Book Value	2.74M	7.44M	7.69M	-5.55M
Book Value Per Share	1.37	6.10	8.86	-7.16
Common Stock	2.34K	1.78K	13.02K	8.19K
Retained Earnings	-38.96M	-25.72M	-15.07M	-6.71M
Comprehensive Income	n/a	n/a	n/a	n/a
Shareholders Equity	2.74M	7.44M	7.69M	-5.55M
Total Investments	n/a	n/a	n/a	n/a